Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleBRENTUXIMAB VEDOTIN PLUS CHP AS FIRST‐LINE TREATMENT IN CD30 + PERIPHERAL T‐CELL LYMPHOMAS: REAL LIFE EXPERIENCE FROM A SINGLE INSTITUTION IN SPAIN.AuthorsDomingo Domenech, E.; Sancho Cia, J. M.; Gonzalez Barca, E.; Kelleher, N.; Rodriguez‐Luaces, M.; Rovira, J.; Verdesoto, S.; Encuentra, M.; Blazevic, D.; Oliveira, A.; Escoda, L.; Ribera, J. M.; Sureda, A.PublicationHematological Oncology, 2021, Vol 39, p1ISSN0278-0232Publication typeArticleDOI10.1002/hon.73_2881